VEGFA and chronic kidney disease: However, in a scenario of increased circulating sFlt-1 and normal-to-decreased VEGF levels—as described in renal pathologies, such as CKD—sFlt-1, could be a relevant contributor to barrier dysfunction [9,37] at least as an important indicator of loss of endothelial integrity.